PNC Financial Services Group
BLTE

PNC Financial Services Group’s Belite Bio BLTE Stock Holding History

PNC Financial Services Group’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8
Closed -$505 – 4907
2024
Q4 		$505 Buy
+8
New +$527 ﹤0.01% 4526

Other funds holding BLTE

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $363M AUM 34.89% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

PNC Financial Services Group's BLTE Position: Q1 2025 in Review

PNC Financial Services Group sold out of Belite Bio (BLTE) in Q1 2025, closing a stake of 8 shares — an estimated $505 sold.

PNC Financial Services Group first reported a position in BLTE in Q4 2024 and held it in 1 quarter. The position peaked at $505 in Q4 2024. 18 funds tracked by Wall St. Rank hold BLTE as of Q1 2025.

  • PNC Financial Services Group reported no remaining Belite Bio position as of Q1 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 8 Belite Bio shares in Q1 2025, an estimated $505.
  • PNC Financial Services Group first reported a position in Belite Bio in Q4 2024 and held it in 1 quarter.
  • PNC Financial Services Group's Belite Bio position peaked at $505 in Q4 2024.
  • 18 funds tracked by Wall St. Rank held Belite Bio as of Q1 2025.

Based on PNC Financial Services Group's 13F filing for Q1 2025, filed 9 May 2025.